Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Orchestra BioMed Holdings (OBIO) Leases (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Leases for 4 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Leases fell 28.86% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 28.86% year-over-year, with the annual reading at $1.5 million for FY2025, 28.86% down from the prior year.
  • Leases for Q4 2025 was $1.5 million at Orchestra BioMed Holdings, down from $1.7 million in the prior quarter.
  • The five-year high for Leases was $2.2 million in Q4 2022, with the low at $1.3 million in Q2 2024.
  • Average Leases over 4 years is $1.8 million, with a median of $1.7 million recorded in 2023.
  • The sharpest move saw Leases decreased 28.98% in 2024, then skyrocketed 35.69% in 2025.
  • Over 4 years, Leases stood at $2.2 million in 2022, then fell by 28.9% to $1.6 million in 2023, then surged by 35.24% to $2.1 million in 2024, then fell by 28.86% to $1.5 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $1.5 million, $1.7 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.